Global Tuberculosis (TB) Diagnostics Competitive Landscape Professional Research Report 2025

Research Summary

Tuberculosis (TB) diagnostics encompass a range of tests and methods aimed at identifying and confirming the presence of tuberculosis infection in individuals. One of the primary diagnostic tools is the tuberculin skin test (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium tuberculosis DNA in clinical samples. Chest X-rays are often employed to visualize lung abnormalities associated with active TB. More recently, interferon-gamma release assays (IGRAs) have been developed to measure the immune response to specific TB antigens. Culturing of samples, typically sputum, can definitively confirm the presence of the bacteria. TB diagnostics play a critical role in early detection, treatment initiation, and the overall management of tuberculosis, a contagious infectious disease that poses significant global health challenges.

According to DIResearch's in-depth investigation and research, the global Tuberculosis (TB) Diagnostics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Tuberculosis (TB) Diagnostics include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Tuberculosis (TB) Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Tuberculosis (TB) Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Tuberculosis (TB) Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Tuberculosis (TB) Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Tuberculosis (TB) Diagnostics Include:

Danaher

Roche

Thermo Fisher Scientific

BD

Abbott

Hologic

Qiagen

BioMerieux

Hain Lifescience

Oxford Immunotec

Tuberculosis (TB) Diagnostics Product Segment Include:

Culture-Based Diagnostics

Sputum Smear Microscopy

Rapid Molecular Diagnostics

Others

Tuberculosis (TB) Diagnostics Product Application Include:

Diagnostic Laboratories

Hospitals

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Tuberculosis (TB) Diagnostics Industry PESTEL Analysis

Chapter 3: Global Tuberculosis (TB) Diagnostics Industry Porter’s Five Forces Analysis

Chapter 4: Global Tuberculosis (TB) Diagnostics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Tuberculosis (TB) Diagnostics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources